Tnf Blocker

Crohns disease stock photo

Marketing

BMS' Zeposia, AbbVie drugs shake up early IBD market

The U.S. inflammatory bowel disease market is seeing a shift in what drugs patients are offered for their first prescriptions.

Ben Adams Dec 6, 2022 9:25am

FDA Building 2

EMA probes all JAKs after Xeljanz's safety concerns intensify

Feb 11, 2022 3:51pm

Humira

AbbVie's Humira could have a graceful biosim fall: analyst

Jul 12, 2021 11:27am

Stelara

Long-term study shows safety, staying power of J&J's Stelara

Jul 9, 2021 11:10am

Tremfya

J&J touts Tremfya win in Humira-resistant psoriatic arthritis

Jun 3, 2021 11:40am

Bristol Myers Squibb new sign outside

Bristol's Zeposia boost remission rates in ulcerative colitis

Oct 10, 2020 6:01pm